AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

CMS Invites Comments on Proposed Decision Regarding Coverage of Hepatitis C Screening

cms logo

This week, the Centers for Medicare and Medicaid Services (CMS) released their proposed decision memo for the National Coverage Analysis (NCA) on Medicare coverage for Hepatitis C virus (HCV) screening in adults. They find that “the evidence is adequate to conclude that screening for Hepatitis C Virus (HCV), consistent with the grade B recommendations by…

NIH’s Dr. Carl Dieffenbach Shares Highlights from CROI 2014 – March 4

Carl Dieffenbach at CROI

Yesterday, March 4, was the first full day of the 2014 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston. Over 4,000 HIV/AIDS research leaders from 85 countries are gathered at the annual scientific meeting discussing their work to understand, prevent, and treat HIV/AIDS and related infectious diseases. We’ve invited our colleague Dr. Carl Dieffenbach to…

NMA Experts Release Recommendations to Address Hepatitis C Among African Americans

NMA Report Cover

With an estimated 3.2 million Americans chronically infected with the hepatitis C virus (HCV), and an estimated 75% of them unaware of their infection, the sheer magnitude of the number of persons infected calls the nation to action. Moreover, chronic HCV infection is the most common cause of liver cirrhosis and primary liver cancer, and…

Fighting Hepatitis C Among African Americans

blog.aids.gov

February is Black History Month, a time to commemorate the achievements of African Americans in the United States. It also presents an opportunity to discuss serious health concerns that affect the African American community, including viral hepatitis and especially Hepatitis C. The most common type of viral hepatitis is Hepatitis C, with an estimated 3.2…

U.S. Preventive Services Task Force Seeks Comment on its Draft Recommendation Statement on Hepatitis B Screening for High-Risk Adults

US PSTF Logo

This week, the U.S. Preventive Services Task Force  (USPSTF) issued its draft recommendation statement pertaining to hepatitis B screening, recommending screening people who are at high risk for hepatitis B infection. Before finalizing the recommendation, the USPSTF is inviting public comments on the draft statement until March 10, 2014. The Task Force is an independent group…

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

Online Expert Advice for Clinicians Treating Hepatitis C Now Available

Ronald Valdiserri

Up-to-date guidance for the treatment of hepatitis C virus (HCV) infection is now available for healthcare providers from HCVguidelines.org, a new online resource launched this week by the American Association for the Study of Liver Diseases  (AASLD) and the Infectious Diseases Society of America  (IDSA), in collaboration with the International Antiviral Society-USA   (IAS-USA).  These guidelines are…

FDA approves Sovaldi for chronic hepatitis C

FDA

Drug is third with breakthrough therapy designation to receive FDA approval The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon. “Today’s…